SCHEMBL4682269

SCHEMBL4682269

CC(C[C@H]1CC(n2cnc3ccccc32)CCN1C(=O)O)N(Cc1ccccc1)Cc1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DRD2 P14416 1/20 0.43
▸ SLC6A4 P31645 1/20 0.43
▸ USP2 O75604 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ ALDH1A1 P00352 2/20 0.40
▸ TACR2 P21452 1/20 0.39
▸ OPRM1 P35372 1/20 0.39
▸ OPRL1 P41146 1/20 0.39
▸ CCR5 P51681 2/20 0.38
▸ CYP2C9 P11712 1/20 0.38
▸ IDO1 P14902 1/20 0.38
▸ KCNH2 Q12809 1/20 0.38
▸ PKM P14618 2/20 0.38
▸ FPR2 P25090 1/20 0.36
▸ AGER Q15109 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ APAF1 O14727 1/20 0.36
▸ HRH3 Q9Y5N1 1/20 0.35
▸ TPSAB1 Q15661 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4682266 1.00 DRD2 (0.43) DRD2SLC6A4USP2KMT2AALDH1A1
SCHEMBL4674487 0.83 ALDH1A1 (0.45) USP2KMT2AALDH1A1CCR5KDM4E
SCHEMBL4674486 0.83 ALDH1A1 (0.45) USP2KMT2AALDH1A1CCR5KDM4E
SCHEMBL4682261 0.83 DRD2 (0.44) DRD2SLC6A4USP2KMT2AALDH1A1
SCHEMBL1838649 0.81 DRD2 (0.41) DRD2SLC6A4USP2KMT2AALDH1A1
SCHEMBL4678008 0.80 FPR2 (0.43) KMT2AOPRM1CCR5CYP2C9FPR2
SCHEMBL4678005 0.80 FPR2 (0.43) KMT2AOPRM1CCR5CYP2C9FPR2
SCHEMBL4675602 0.79 CYP3A4 (0.41) DRD2OPRM1OPRL1
SCHEMBL1834088 0.78 USP2 (0.48) DRD2SLC6A4USP2KMT2AALDH1A1
SCHEMBL1831393 0.78 USP2 (0.48) DRD2SLC6A4USP2KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1997805-A1 Compounds with antiparasitic activity, applications thereof to the treatment of infectious diseases caused by apicomplexans Commissariat à l'Energie Atomique (FR) 2008-12-03 — — EP disclosed
Send feedback